The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Assessment of addiction severity among ritual users of ayahuasca.
Abstract
Ayahuasca is a psychoactive beverage used for magico-religious purposes in the Amazon. Recently, Brazilian syncretic churches have helped spread the ritual use of ayahuasca abroad. This trend has raised concerns that regular use of this N,N-dimethyltryptamine-containing tea may lead to the medical and psychosocial problems typically associated with drugs of abuse. Here we assess potential drug abuse-related problems in regular ayahuasca users. Addiction severity was assessed using the Addiction Severity Index (ASI), and history of alcohol and illicit drug use was recorded. In Study 1, jungle-based ayahuasca users (n=56) were compared vs. rural controls (n=56). In Study 2, urban-based ayahuasca users (n=71) were compared vs. urban controls (n=59). Follow-up studies were conducted 1 year later. In both studies, ayahuasca users showed significantly lower scores than controls on the ASI Alcohol Use, and Psychiatric Status subscales. The jungle-based ayahuasca users showed a significantly higher frequency of previous illicit drug use but this had ceased at the time of examination, except for cannabis. At follow-up, abstinence from illicit drug use was maintained in both groups except for cannabis in Study 1. However, differences on ASI scores were still significant in the jungle-based group but not in the urban group. Despite continuing ayahuasca use, a time-dependent worsening was only observed in one subscale (Family/Social relationships) in Study 2. Overall, the ritual use of ayahuasca, as assessed with the ASI in currently active users, does not appear to be associated with the deleterious psychosocial effects typically caused by other drugs of abuse.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ritual use of ayahuasca shows considerable differences to the traditional psychosocial harms of drug consumption (Fábregas et al., 2010).”
From The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization (2016) · cites this paper as Fábregas et al., 2010
Citations
Cites
The Fifth Edition of the Addiction Severity Index.
Mclellan, A., Kushner, H., Metzger, D., Peters, R., Smith, I. E., Grissom, G. R., Pettinati, H., & Argeriou, M. (1992) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(92)90062-s · Cited by 4,280
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Camí, J., & Farré, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023160 · Cited by 477
The pharmacology of lysergic acid diethylamide: A review
Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00059.x · Cited by 455
The Addiction Severity Index at 25: Origins, contributions, and transitions
McLellan, A. T., Cacciola, J. C., Alterman, A. I., Rikoon, S. H., & Carise, C. (2006) · The American Journal on Addictions · doi:10.1080/10550490500528316 · Cited by 450
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390
Self-citationHuman psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.
GROB, C. S., McKENNA, D. J., CALLAWAY, J. C., BRITO, G. S., NEVES, E. S., OBERLAENDER, G., SAIDE, O. L., LABIGALINI, E., TACLA, C., MIRANDA, C. T., et al. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199602000-00004 · Cited by 338
McKenna, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.03.002 · Cited by 321
Vollenweider, F. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00108-0 · Cited by 305
Flesh of the Gods : The Ritual Use of Hallucinogens
Furst, P. T. (1972) · Cited by 258
Cited by
Sorted by citations
Items 101–200 of 227
Nolli, L. M., de Oliveira, D. G. R., Alves, S. S., von Zuben, M. V., Pic‐Taylor, A., Mortari, M. R., & Caldas, E. D. (2019) · Alcohol · doi:10.1016/j.alcohol.2019.10.005 · Cited by 28
Rush, B. R., Marcus, O., García, S., Loizaga-Velder, A. K., Loewinger, G. C., Spitalier, A., & Mendive, F. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.659644 · Cited by 32
Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?
Malcolm, B., & Lee, K. C. (2017) · Mental Health Clinician · doi:10.9740/mhc.2017.01.039 · Cited by 34
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy
Orsolini, L., Chiappini, S., Papanti, D., Latini, R., Volpe, U., Fornaro, M., Tomasetti, C., Vellante, F., & Berardis, D. D. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2728 · Cited by 33
Cox, D. J., Garcia‐Romeu, A., & Johnson, M. W. (2021) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2021.1910830 · Cited by 27
Ayahuasca for the Treatment of Depression
Palhano-Fontes, F., Soares, B. L., Coelho, N. L. G., Arcoverde, E., & de Araújo, D. B. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_277 · Cited by 26
Santos, B. W. L., Moreira, D. C., Borges, T. K. D. S., & Caldas, E. D. (2022) · Molecules · doi:10.3390/molecules27082500 · Cited by 30
Teacher plants — Indigenous Peruvian-Amazonian dietary practices as a method for using psychoactives
Berlowitz, I., O’Shaughnessy, D. M., Heinrich, M., Wolf, U., Maake, C., & Martin-Söelch, C. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114910 · Cited by 31
Tófoli, L. F., & de Araújo, D. B. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.06.005 · Cited by 35
Kohek, M., Ona, G., van Elk, M., Dos Santos, R. G., Hallak, J. E. C., Alcázar-Córcoles, M. Á., & Bouso, J. C. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2077155 · Cited by 24
Self-citationAyahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity
Gianfratti, B., Tabach, R., Sakalem, M. E., Stessuk, T., Maia, L. O., & Carlini, E. A. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114865 · Cited by 25
Personality Traits in Former Spanish Substance Users Recovered with Ayahuasca
Apud Peláez, I. E. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1752960 · Cited by 22
Ceremonial ‘Plant Medicine’ use and its relationship to recreational drug use: an exploratory study
Dorsen, C. G., Palamar, J. J., & Shedlin, M. G. (2018) · Addiction Research & Theory · doi:10.1080/16066359.2018.1455187 · Cited by 23
Labate, B. C., & Cavnar, C. (2010) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2010.09.002 · Cited by 22
Psychedelics in the Treatment of Substance Use Disorders and Addictive Behaviors: A Scoping Review
Richard, J., & Garcia‐Romeu, A. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00629-8 · Cited by 22
The current state of ayahuasca research in animal models: A systematic review
Daldegan‐Bueno, D., Simionato, N. M., Favaro, V. M., & Maia, L. O. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110738 · Cited by 21
Cowley‐Court, T., Chenhall, R. D., Sarris, J. J., Bouso, J. C., Tófoli, L. F., Opaleye, E. S., Schubert, V., & Perkins, D. (2023) · Psychoactives · doi:10.3390/psychoactives2020014 · Cited by 20
Self-citationHogea, L., Tabugan, D. C., Costea, I., Albai, O., Nussbaum, L. A., Cojocaru, A., Corsaro, L., & Anghel, T. (2025) · Medicina · doi:10.3390/medicina61020278 · Cited by 19
A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment
Burdick, B. V., & Adinoff, B. H. (2013) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.811513 · Cited by 19
Immunological Effects of Ayahuasca in Humans
SANTOS, R. G. D. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2014.960113 · Cited by 18
Socha, D. M., Sykutera, M., & Orefici, G. (2022) · Journal of Archaeological Science · doi:10.1016/j.jas.2022.105688 · Cited by 17
Basedow, L. A., Riemer, T., Reiche, S., Kreutz, R. H., & Majić, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739966 · Cited by 17
Vorobyeva, N. S., & Kozlova, A. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.927984 · Cited by 20
It’s Tea Time: Interference of Ayahuasca Brew on Discriminative Learning in Zebrafish
Soares, B. L., Eduardo-da-Silva, P., Amarilha, H., Pinheiro‐da‐Silva, J., Silva, P. F., & Luchiari, A. C. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00190 · Cited by 17
Hypotheses Regarding Ayahuasca’s Potential Mechanisms of Action in the Treatment of Addiction
Prickett, J. I., & Liester, M. B. (2013) · Springer eBooks · doi:10.1007/978-3-642-40426-9_7 · Cited by 18
Natural Product (Fungal and Herbal) Novel Psychoactive Substances
Gibbons, S., & Arunotayanun, W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415816-0.00014-6 · Cited by 16
Kohek, M., Avilés, C. S., Romaní, O., & Bouso, J. C. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103390 · Cited by 15
Self-citationWeiss, B., Sleep, C. E., Beller, N. M., Erritzøe, D., & Campbell, W. K. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00291 · Cited by 15
Ayahuasca: Pharmacology, Safety, and Therapeutic Effects
SANTOS, R. G. D., & Hallak, J. E. C. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009585330.005 · Cited by 20
Integrating Psychedelic Medicines and Psychiatry: Theory and Methods of a Model Clinic
Sloshower, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-76720-8_7 · Cited by 16
Effect of Ritualistic Consumption of Ayahuasca on Hepatic Function in Chronic Users
Mello, S. M., Soubhia, P. C., Silveira, G. D. O., Correa-Netto, N. F., Lanaro, R., Costa, J. L., & Linardi, A. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1557355 · Cited by 19
Apud, I., Scuro, J., Carrera, I., & Oliveri, A. (2022) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2053004 · Cited by 14
Psychedelics: From Cave Art to 21st-Century Medicine for Addiction
Vamvakopoulou, I. A., & Nutt, D. J. (2024) · European Addiction Research · doi:10.1159/000540062 · Cited by 18
Analysis of 28 hair samples from users of the hallucinogenic beverage ayahuasca
Liu, M., Yang, H., Hu, J., Shen, B., Xiang, P., Qiang, H., Deng, H., Yu, Z., & Shi, Y. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.110790 · Cited by 15
Sanchez, T. A., Ramos, L. R., Araujo, F., Schenberg, E. E., Yonamine, M., Lobo, I., de Araújo, D. B., & Luna, L. E. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117430 · Cited by 14
The enchanted snake and the forbidden fruit: the ayahuasca ‘fairy tale’ tourist
Dean, A. K. (2019) · Journal of Marketing Management · doi:10.1080/0267257x.2019.1601635 · Cited by 13
Yaden, D. B., Berghella, A. P., Hendricks, P. S., Yaden, M. E., Levine, M., Rohde, J. S., Nayak, S. M., Johnson, M. W., & Garcia‐Romeu, A. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106998 · Cited by 13
Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents
Carlini, E. A., & Maia, L. O. (2017) · Toxinology · doi:10.1007/978-94-007-6464-4_6 · Cited by 13
Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior
Grilo, M. L. P. D. M., de Sousa, G. M., de Mendonça, L. A. C., Soares, B. L., de Sousa, M. B. C., Palhano-Fontes, F., de Araújo, D. B., Perkins, D., Hallak, J. E. C., & Coelho, N. L. G. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.901425 · Cited by 16
Nižňanský, Ľ., Nižnanská, Ž., Kuruc, R., Szórádová, A., Šikuta, J., & Zummerová, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11041147 · Cited by 13
Echeverry, C., Pazos, M., Torres‐Pérez, M., & Prunell, G. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.039 · Cited by 12
Ayahuasca: Between Cognition and Culture
Peláez, I. E. A. (2020) · Publicacions URV eBooks · doi:10.17345/9788484248347 · Cited by 11
Sayin, H. U. (2014) · Cited by 10
Ayahuasca in the Czech Republic: Extended Version
Horák, M., & Verter, N. (2019) · doi:10.11118/978-80-7509-657-9 · Cited by 10
Weleff, J., Nunes, J. C., Costa, G. P. A., Sofuoglu, M., MacLean, R. R., & Aquino, J. P. D. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16045 · Cited by 12
Classic psychedelics and the treatment for alcoholism
Lodetti, G., de Bitencourt, R. M., & Rico, E. P. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111129 · Cited by 11
Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay
Kummrow, F., Maselli, B. D. S., Lanaro, R., Costa, J. L., Umbuzeiro, G. D. A., & Linardi, A. (2018) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22263 · Cited by 11
A Scoping Review of Research in Naturalistic Studies with Psychedelics
de Carvalho, L. L., Encantado, J., Kettner, H., Timmermann, C., Veiga, D., & Teixeira, P. J. (2025) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2025.2520221 · Cited by 10
Plants with Anti-Addictive Potential
Konrath, E. L., Arbo, M. D., Arbo, B. D., Hort, M. A., Elisabetsky, E., & Leal, M. B. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-64872-5_14 · Cited by 10
Zkušenost s halucinogenní rostlinou ayahuasca v kontextu šamanského rituálu
Kavenská, V., & Šimonová, H. (2014) · Anthropologia integra · doi:10.5817/ai2014-1-51 · Cited by 9
Cortical structural differences following repeated ayahuasca use hold molecular signatures
Mallaroni, P., Mason, N. L., Kloft, L., Reckweg, J. T., van Oorsouw, K. I. M., & Ramaekers, J. G. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1217079 · Cited by 8
Hilal, F. F., Jeanblanc, J., Deschamps, C., Naassïla, M., Pierrefiche, O., & Hamida, S. B. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02757-3 · Cited by 8
Mapping Psilocybin-Assisted Therapies: A Scoping ReviewPreprint
Shore, R., Ioudovski, P., Goldie, C. E., McKeown, S., & Dumont, É. C. (2019) · medRxiv · doi:10.1101/2019.12.04.19013896 · Cited by 8
Episodios psicóticos inducidos por ayahuasca: revisión sistemática a partir de un caso.
Alcantarilla, L., García-Alcarria, E., & Almonacid, C. (2022) · Revista de Neuro-Psiquiatría · doi:10.20453/rnp.v85i3.4331 · Cited by 9
Exploring the therapeutic potential of psychedelics in treating substance use disorders
Li, Y., Li, H., Wang, H., & Wang, X. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03168-w · Cited by 6
Ayahuasca for the treatment of alcohol use disorder
Marinho, E. A. V., Serra, Y. A., Oliveira-Lima, A. J., Marcourakis, T., & Berro, L. F. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.07.007 · Cited by 10
Psychedelics and substance use disorder treatment
DuPont, C. M., & Johnson, M. W. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.005 · Cited by 8
Ayahuasca and Psychotherapy: Beyond Integration
Diament, M., Gomes, B., & Tófoli, L. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_4 · Cited by 7
Therapeutic Use of Hallucinogens
Wiltenburg, V. D., Prado, D. D. R., & Mendes, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-62855-0_35 · Cited by 1
Argento, E., Capler, R., THOMAS, G. W., Lucas, P., & Tupper, K. W. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_10 · Cited by 6
Ayahuasca as an Addiction Treatment in Catalonia: Cognitive and Cultural Perspectives
Apud, I. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_9 · Cited by 6
Apud, I., Scuro, J., Carrera, I., & Oliveri, A. (2022) · Journal of Psychedelic Studies · doi:10.1556/2054.2022.00202 · Cited by 7
Ayahuasca: el encuentro de dos paradigmas.
Rojas-Bolívar, D. (2014) · Revista de Neuro-Psiquiatría · doi:10.20453/rnp.v77i1.1162 · Cited by 7
Horák, M. (2017) · Mendelova univerzita v Brně eBooks · doi:10.11118/978-80-7509-510-7 · Cited by 6
Myers, M. G., & Toal, C. B. (1995) · PubMed · Cited by 6
Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms
Tariq, R. (2022) · Current Clinical Pharmacology · doi:10.2174/2772432817666220321142707 · Cited by 5
Bhatt, S. R., Armstrong, M., Parker, T., Maviglia, M. A., Kass, R., Leeman, L. M., Romo, P., & Ziedonis, D. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.905753 · Cited by 8
Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action
Miller, E. A., Capone, C., Eaton, E. M., Swift, R. M., & Haass‐Koffler, C. L. (2025) · CNS Drugs · doi:10.1007/s40263-025-01199-z · Cited by 6
Griffin, C., & Knight, A. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00333 · Cited by 4
Scuro, J., Apud, I., & Martínez, V. (2024) · Anthropology of Consciousness · doi:10.1111/anoc.12242 · Cited by 4
Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents
Carlini, E. A., & Maia, L. O. (2019) · Toxinology · doi:10.1007/978-94-007-6728-7_6-2 · Cited by 4
Acute antidepressant effect of ayahuasca in juvenile non-human primate model of depressionPreprint
da Silva, F. S., Silva, E. A. D. S., de Sousa, G. M., Maia‐de‐Oliveira, J. P., Soares-Rachetti, V. D. P., de Araújo, D. B., de Sousa, M. B. C., Soares, B. L., & Coelho, N. L. G. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/254268 · Cited by 4
The current state of ayahuasca research in animal models: A systematic reviewPreprint
Daldegan‐Bueno, D., Simionato, N. M., Favaro, V. M., & Maia, L. O. (2022) · doi:10.31234/osf.io/7s3b8 · Cited by 4
Psychedelics for substance use disorders: are women being addressed? A scoping review
Nigri, A. W., de Arruda, I. F., Maia, C. G. F., Tófoli, L. F., & Carezzato, F. (2025) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2025.104960 · Cited by 3
Lima, G., Soares, C., Teixeira, M., & Castelo-Branco, M. S. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16264 · Cited by 3
Latin American adults who regularly use macrodoses of psychedelics: a cross-sectional study
Véliz‐García, Ó., & Domic‐Siede, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-74590-3 · Cited by 4
Phipps, S. M., & Grundmann, O. (2017) · Studies in natural products chemistry · doi:10.1016/b978-0-444-63930-1.00001-6 · Cited by 3
Ayahuasca, Harmala Alkaloids, and Dimethyltryptamines
Barceloux, D. G. (2012) · doi:10.1002/9781118105955.ch53 · Cited by 3
Aicher, H., Wicki, I. A., Meling, D., Mueller, M. J., Dornbierer, D., & Scheidegger, M. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251344689 · Cited by 2
Mehtani, N. J., Mian, M. N., Agin-Liebes, G., Coker, A. R., Huebner, C., Anderson, B. T., & Mitchell, J. (2025) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2025.2583960 · Cited by 2
de Sousa, P. C. M., de Sousa, I. N. A., Leite, L. L. L., Oliveira, A. L. O., Souza, K. A. D. S., Soares, J. D. S., Viana, M. D. R., & do Amaral, M. P. D. M. (2021) · Research Society and Development · doi:10.33448/rsd-v10i4.14251 · Cited by 3
In Becoming. Instability of Psychedelic Substances
Sadowska, Z. (2022) · Etnografia Polska · doi:10.23858/ep66.2022.2834 · Cited by 2
Matoc, M. S., Stiperski, Z., & Hruška, T. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1003821 · Cited by 4
Vargas-Pérez, H., Minauro‐Sanmiguel, F., Ting‐A‐Kee, R. A., Grieder, T. E., Méndez‐Díaz, M., Prospero-Garcia, O. E., & van der Kooy, D. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137597 · Cited by 3
Fluyau, D., Kailasam, V. K., & Revadigar, N. (2024) · Psychoactives · doi:10.3390/psychoactives3040029 · Cited by 2
Ayahuasca drinking using a two-bottle choice procedure in male mice
Kisaki, N. D., Serra, Y. A., Rodrigues, I. R. S., Silva, K. S. O., Jovita-Farias, C., Alves, G. L., Bezerra, M. T., Gaburro-Ribeiro, I., Leite, J. P., de Jesus, N. M. S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-75077-x · Cited by 2
Do Hallucinogens Have a Role in the Treatment of Addictions? A Review of the Current Literature
Nigam, K. B., & Pandurangi, A. K. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-00871-x · Cited by 2
Revisión bibliográfica de la ayahuasca y su uso terapéutico
Castillo, E. C., Castillo, C. C., & Godoyc, J. Z. (2020) · Revista Peruana de Medicina Integrativa · doi:10.26722/rpmi.2020.v5n3.251 · Cited by 2
Could Psychedelics Treat Neuropathic Chronic Pain?
(2023) · Neurological Sciences and Neurosurgery · doi:10.47275/2692-093x-130 · Cited by 1
Scuro, J. (2023) · Ciencias Sociales y Religión · doi:10.20396/csr.v25i00.8672228 · Cited by 2
Psychedelics for the Treatment of Substance Use Disorders
Klaus, J., Schneider, F., Schaletzky, R., Sippel, D., & Batra, A. (2025) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/0939-5911/a000953 · Cited by 2
Wallace, L. M., Bujor, A., Sudre, G. P., Kennedy, M., Bahnareanu, D.-E., & Mittal, K. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261430518 · Cited by 1
Postránecká, Z., Lucký, M., Mravčík, V., & Páleníček, T. (2026) · Journal of Psychedelic Studies · doi:10.1556/2054.2026.00514 · Cited by 1
Ayahuasca: From Ethnobotany to Pharmacology
Guilherme, J., Martin, P., Barancelli, G. V., Porto, E., & Tiwari, S. (2012) · Cited by 1
Pablo Bonilla, R., Tuesta, A. T., Rebaza, G. A. F., Melo, D. C., Gutierrez, R. R., Tantaraico, E. C. S., Quintana, A. D. B., Guerra, G. I. M., Santacruz, K. S., Herrera, L. M., et al. (2021) · Revista Peruana de Medicina Integrativa · doi:10.26722/rpmi.2020.53.181 · Cited by 1
Greene, S. L. (2025) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2024.12.002 · Cited by 1
Yerima, M., Onifade, P. O., Wakawa, I. A., Pindar, S., Jidda, M. S., Musami, U. B., & Ali, F. A. (2020) · Nigerian Medical Journal · doi:10.4103/nmj.nmj_59_19 · Cited by 1
Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents
Carlini, E. A., & Maia, L. O. (2015) · Springer eBooks · doi:10.1007/978-94-007-6728-7_6-1 · Cited by 1
Ayahuasca: farmacología, efectos agudos, potencial terapéutico y rituales
Aliño, M., Gadea, M., Miguel, J. P. S., & Espert, R. (2015) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia) · Cited by 1
McIlhenny, E. H. (2012) · doi:10.31390/gradschool_dissertations.2049 · Cited by 1
Metadata
- Authors
- Fábregas, J. M., González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P. C. R., Alcázar-Córcoles, M. Á., Barbanoj, M. J., Riba, J., & Bouso, J. C.
- Affiliations
- Universidad Complutense de Madrid (ES)
- Universidade Estadual de Santa Cruz (BR)
- Universitat Autònoma de Barcelona (ES)
- Hospital de Sant Pau (ES)
- Corresponding author
- Bouso, José Carlos
- ORCID
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 111
- Issue
- 3
- Pages
- 257-261
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2116852450
- Cited by
- 227
- References
- 25
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 18 · 2023: 16 · 2022: 25 · 2021: 28 · 2020: 11 · 2019: 15 · 2018: 17 · 2017: 11 · 2016: 15 · 2015: 11 · 2014: 7 · 2013: 11 · 2012: 13
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug and Alcohol Dependence (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- ayahuasca, ritual drug use, addiction severity, N,N-dimethyltryptamine, illicit drug use, cannabis use, alcohol consumption, psychosocial impact, family and social relationships, Addiction Severity Index
- MeSH terms
- Adult, Brazil, Ceremonial Behavior, Female, Follow-Up Studies, Humans, Male, Middle Aged, Severity of Illness Index, Illicit Drugs, Behavior, Addictive, Substance-Related Disorders, Banisteriopsis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review